9 results on '"Le Marec H"'
Search Results
2. P5441Aortic valve phenotype associated with filamin-A mutations: a comprehensive echocardiographic and outcomes analyses
- Author
-
Capoulade, R, primary, Cueff, C, additional, Piriou, N, additional, Toquet, C, additional, Blandin, S, additional, Guimbretiere, G, additional, Omen, T, additional, Aalberts, J, additional, Bernstein, D, additional, Bernstein, J, additional, Trochu, J N, additional, Le Marec, H, additional, Merot, J, additional, Schott, J J, additional, and Le Tourneau, T, additional
- Published
- 2018
- Full Text
- View/download PDF
3. Comparison between flecainide and ajmaline challenge in Brugada syndrome patients
- Author
-
Probst, V., primary, Gourraud, J. B., additional, Chatel, S., additional, Mansourati, J., additional, Sacher, F., additional, Babuty, D., additional, Mabo, P., additional, and Le Marec, H., additional
- Published
- 2013
- Full Text
- View/download PDF
4. Clinical presentation and short-term effect of hydroquinidine in Brugada syndrome patients included in the QUIDAM study
- Author
-
Probst, V., primary, Lennhardt, A., additional, Babuty, D., additional, Mabo, P., additional, Pasquier, J. L., additional, Mansourati, J., additional, Maury, P., additional, Sacher, F., additional, Gourraud, J. B., additional, and Le Marec, H., additional
- Published
- 2013
- Full Text
- View/download PDF
5. Characteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: a multicentre study
- Author
-
Baruteau, A.-E., primary, Fouchard, S., additional, Behaghel, A., additional, Mabo, P., additional, Villain, E., additional, Thambo, J.-B., additional, Marcon, F., additional, Gournay, V., additional, Rouault, F., additional, Chantepie, A., additional, Guillaumont, S., additional, Godart, F., additional, Bonnet, C., additional, Fraisse, A., additional, Schleich, J.-M., additional, Lusson, J.-R., additional, Dulac, Y., additional, Leclercq, C., additional, Daubert, J.-C., additional, Schott, J.-J., additional, Le Marec, H., additional, and Probst, V., additional
- Published
- 2011
- Full Text
- View/download PDF
6. Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype.
- Author
-
Lande, G., Kyndt, F., Baró, I., Chabannes, D., Boisseau, P., Pony, J.-C., Escande, D., and Le Marec, H.
- Abstract
Aims In families with the long QT syndrome penetrance may be low: up to 70% of gene carriers may have a normal QTc interval. These patients require therapy, similar to that in those with longer QTc intervals, but identifying them, using molecular analysis, is difficult to apply on a large scale. A large French family affected by the long QT1 syndrome was followed-up over a 25-year period. In adult males but not in females, the QTc interval normalized after puberty. We aimed to find clinical criteria, based on ambulatory ECG recordings so that we could improve diagnosis in affected members with a normal QTc.Methods and Results Linkage analysis and direct sequencing were an indicator of the long QT1 gene in our family. Reverse transcription-polymerase chain reaction analysis demonstrated abnormal transcripts in lymphocytes from silent gene carriers. The functional profile of mutated protein isoforms was investigated using the patch–clamp technique. Dynamic analysis of ventricular depolarization was conducted using Holter recordings in patients, and in sex- and age-matched controls. Circadian variations of the QTc interval and the QT/RR relationship were assessed. Sensitivity, specificity, and predictive values were evaluated for proposed clinical criteria. We found that dynamic analysis of the QT interval permitted individual diagnosis in mutation carriers even when the QTc interval was normal (adult males).Conclusion Dynamic analysis of the QT interval is of diagnostic value in the long QT1 syndrome in patients with a normal phenotype. Clinical implications include improvement in screening and patient management. [ABSTRACT FROM PUBLISHER]
- Published
- 2001
- Full Text
- View/download PDF
7. SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups
- Author
-
Michael J. Ackerman, Sonia Franciosi, Carla Spazzolini, Peter J. Schwartz, Laura Zahavich, Annika Winbo, Anna Joong, Hervé Le Marec, Arja S. Vink, Andrew D. Krahn, Isabelle Denjoy, Mangesh Jadhav, Béatrice Guyomarc’h-Delasalle, Virginie Beauséjour-Ladouceur, Johan M Bos, Nico A. Blom, Alban-Elouen Baruteau, Matthias Lachaud, Claudine Rieubland, Jean Marc Lupoglazoff, Minoru Horie, Yanushi D. Wijeyeratne, Peter C. Ruben, Mena Abdelsayed, Jonathan R. Skinner, Elijah R. Behr, George F. Van Hare, Dominic Abrams, Takeshi Aiba, Jean-Baptiste Gourraud, Arthur A.M. Wilde, Junichi Ozawa, Tak-cheung Yung, Wataru Shimizu, Jacob Tfelt-Hansen, Leonardo Liberman, Lia Crotti, Sit Yee Kwok, Anne M. Dubin, David J. Tester, Shubhayan Sanatani, Vincent Probst, Juan Pablo Kaski, Andrew M. Davis, Federica Dagradi, Elizabeth A. Stephenson, Véronique Fressart, Boris Rudic, Leonie C.H. Wong, F. Kyndt, Jean-Jacques Schott, Baruteau, A, Kyndt, F, Behr, E, Vink, A, Lachaud, M, Joong, A, Schott, J, Horie, M, Denjoy, I, Crotti, L, Shimizu, W, Bos, J, Stephenson, E, Wong, L, Abrams, D, Davis, A, Winbo, A, Dubin, A, Sanatani, S, Liberman, L, Kaski, J, Rudic, B, Kwok, S, Rieubland, C, Tfelt-Hansen, J, Van Hare, G, Guyomarc'h-Delasalle, B, Blom, N, Wijeyeratne, Y, Gourraud, J, Le Marec, H, Ozawa, J, Fressart, V, Lupoglazoff, J, Dagradi, F, Spazzolini, C, Aiba, T, Tester, D, Zahavich, L, Beauséjour-Ladouceur, V, Jadhav, M, Skinner, J, Franciosi, S, Krahn, A, Abdelsayed, M, Ruben, P, Yung, T, Ackerman, M, Wilde, A, Schwartz, P, Probst, V, Amsterdam Cardiovascular Sciences, Graduate School, ACS - Heart failure & arrhythmias, Cardiology, and Paediatric Cardiology
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,BIO/18 - GENETICA ,610 Medicine & health ,030204 cardiovascular system & hematology ,Lower risk ,Asymptomatic ,NAV1.5 Voltage-Gated Sodium Channel ,03 medical and health sciences ,Electrocardiography ,0302 clinical medicine ,Cardiac Conduction System Disease ,Interquartile range ,Loss of Function Mutation ,Risk Factors ,Internal medicine ,Genotype ,Cardiac conduction ,Medicine ,Humans ,Child ,Genetic Association Studies ,Brugada syndrome ,Brugada Syndrome ,Retrospective Studies ,business.industry ,Age Factors ,Infant, Newborn ,Infant ,Retrospective cohort study ,MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE ,medicine.disease ,Brugada syndrome, Genotype–phenotype correlation, Long QT syndrome, Progressive cardiac conduction disorders, SCN5A, Sodium channelopathy ,Long QT Syndrome ,030104 developmental biology ,Child, Preschool ,Gain of Function Mutation ,Cohort ,Asymptomatic Diseases ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Aims To clarify the clinical characteristics and outcomes of children with SCN5A-mediated disease and to improve their risk stratification. Methods and results A multicentre, international, retrospective cohort study was conducted in 25 tertiary hospitals in 13 countries between 1990 and 2015. All patients ≤ 16 years of age diagnosed with a genetically confirmed SCN5A mutation were included in the analysis. There was no restriction made based on their clinical diagnosis. A total of 442 children {55.7% boys, 40.3% probands, median age: 8.0 [interquartile range (IQR) 9.5] years} from 350 families were included; 67.9% were asymptomatic at diagnosis. Four main phenotypes were identified: isolated progressive cardiac conduction disorders (25.6%), overlap phenotype (15.6%), isolated long QT syndrome type 3 (10.6%), and isolated Brugada syndrome type 1 (1.8%); 44.3% had a negative electrocardiogram phenotype. During a median follow-up of 5.9 (IQR 5.9) years, 272 cardiac events (CEs) occurred in 139 (31.5%) patients. Patients whose mutation localized in the C-terminus had a lower risk. Compound genotype, both gain- and loss-of-function SCN5A mutation, age ≤ 1 year at diagnosis in probands and age ≤ 1 year at diagnosis in non-probands were independent predictors of CE. Conclusion In this large paediatric cohort of SCN5A mutation-positive subjects, cardiac conduction disorders were the most prevalent phenotype; CEs occurred in about one-third of genotype-positive children, and several independent risk factors were identified, including age ≤ 1 year at diagnosis, compound mutation, and mutation with both gain- and loss-of-function.
- Published
- 2017
- Full Text
- View/download PDF
8. New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study.
- Author
-
Le Tourneau T, Le Scouarnec S, Cueff C, Bernstein D, Aalberts JJJ, Lecointe S, Mérot J, Bernstein JA, Oomen T, Dina C, Karakachoff M, Desal H, Al Habash O, Delling FN, Capoulade R, Suurmeijer AJH, Milan D, Norris RA, Markwald R, Aikawa E, Slaugenhaupt SA, Jeunemaitre X, Hagège A, Roussel JC, Trochu JN, Levine RA, Kyndt F, Probst V, Le Marec H, and Schott JJ
- Subjects
- Adolescent, Adult, Echocardiography, Female, Genotype, Humans, Male, Middle Aged, Mitral Valve diagnostic imaging, Mutation genetics, Phenotype, Prognosis, Retrospective Studies, Risk Factors, Young Adult, Filamins genetics, Mitral Valve pathology, Mitral Valve Prolapse genetics, Mitral Valve Prolapse pathology
- Abstract
Aims: Filamin-A (FLNA) was identified as the first gene of non-syndromic mitral valve dystrophy (FLNA-MVD). We aimed to assess the phenotype of FLNA-MVD and its impact on prognosis., Methods and Results: We investigated the disease in 246 subjects (72 mutated) from four FLNA-MVD families harbouring three different FLNA mutations. Phenotype was characterized by a comprehensive echocardiography focusing on mitral valve apparatus in comparison with control relatives. In this X-linked disease valves lesions were severe in men and moderate in women. Most men had classical features of mitral valve prolapse (MVP), but without chordal rupture. By contrast to regular MVP, mitral leaflet motion was clearly restricted in diastole and papillary muscles position was closer to mitral annulus. Valvular abnormalities were similar in the four families, in adults and young patients from early childhood suggestive of a developmental disease. In addition, mitral valve lesions worsened over time as encountered in degenerative conditions. Polyvalvular involvement was frequent in males and non-diagnostic forms frequent in females. Overall survival was moderately impaired in men (P = 0.011). Cardiac surgery rate (mainly valvular) was increased (33.3 ± 9.8 vs. 5.0 ± 4.9%, P < 0.0001; hazard ratio 10.5 [95% confidence interval: 2.9-37.9]) owing mainly to a lifetime increased risk in men (76.8 ± 14.1 vs. 9.1 ± 8.7%, P < 0.0001)., Conclusion: FLNA-MVD is a developmental and degenerative disease with complex phenotypic expression which can influence patient management. FLNA-MVD has unique features with both MVP and paradoxical restricted motion in diastole, sub-valvular mitral apparatus impairment and polyvalvular lesions in males. FLNA-MVD conveys a substantial lifetime risk of valve surgery in men.
- Published
- 2018
- Full Text
- View/download PDF
9. Characteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: a multicentre study.
- Author
-
Baruteau AE, Fouchard S, Behaghel A, Mabo P, Villain E, Thambo JB, Marçon F, Gournay V, Rouault F, Chantepie A, Guillaumont S, Godart F, Bonnet C, Fraisse A, Schleich JM, Lusson JR, Dulac Y, Leclercq C, Daubert JC, Schott JJ, Le Marec H, and Probst V
- Subjects
- Adolescent, Adult, Age of Onset, Atrioventricular Block congenital, Atrioventricular Block diagnosis, Bundle-Branch Block diagnosis, Bundle-Branch Block etiology, Child, Child, Preschool, Disease Progression, Disease-Free Survival, Electrocardiography, Female, Humans, Infant, Male, Pacemaker, Artificial, Pregnancy, Prenatal Diagnosis, Retrospective Studies, Risk Factors, Treatment Outcome, Young Adult, Atrioventricular Block therapy, Cardiac Pacing, Artificial methods
- Abstract
Aims: The natural history of congenital or childhood non-immune, isolated atrioventricular (AV) block is poorly defined., Methods and Results: We retrospectively studied 141 children with isolated, non-immune AV block diagnosed in utero, or up to 15 years of age, at 13 French medical centres, between 1980 and 2009. Patients with structural heart disease or maternal antibodies were excluded. Atrioventricular block was asymptomatic in 119 (84.4%) and complete in 100 (70.9%) patients. There was progression to complete AV block in 29/41 (70.7%) patients with incomplete AV block over 2.8 ± 3.4 years (1-155 months), but all patients with incomplete AV block may not have been included in the study. Narrow QRS complex was present in 18 of 26 patients (69.2%) with congenital, and 106 of 115 (92.2%) with childhood AV block. Pacemakers were implanted in 112 children (79.4%), during the first year of life in 18 (16.1%) and before 10 years of age in 90 (80.4%). The mean interval between diagnosis of AV block and pacemaker implants was 2.6 ± 3.9 years (0-300 months). The pacing indication was prophylactic in 70 children (62.5%). During a mean follow-up of 11.6 ± 6.7 years (1-32 years), no patient died or developed dilated cardiomyopathy (DCM). The long-term follow-up was uncomplicated in 127 children (90.1%)., Conclusion: In this large multicentre study, the long-term outcome of congenital or childhood non-immune, isolated AV block was favourable, regardless of the patient's age at the time of diagnosis. No patient died or developed DCM, and pacemaker-related complications were few.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.